Test your knowledge on optimizing bone protection in patients with breast cancer

Which bone density score range indicates osteopenia, with a risk of developing osteoporosis?
-1.0 to -2.5
0 to 1
-1.0 to 0
-0.5 to -1.0
NCCN Guidelines recommend which of the following for patients with breast cancer receiving an aromatase inhibitor who are at risk for osteoporosis?
CBC
Dental care evaluation
Baseline bone density scan
All of the above
Dosing indications for denosumab are different for treating osteoporosis than for prevention of skeletal-related events in metastatic breast cancer.
True
False
{"name":"Test your knowledge on optimizing bone protection in patients with breast cancer", "url":"https://www.poll-maker.com/QE9RS2PDO","txt":"Which bone density score range indicates osteopenia, with a risk of developing osteoporosis?, NCCN Guidelines recommend which of the following for patients with breast cancer receiving an aromatase inhibitor who are at risk for osteoporosis?, Dosing indications for denosumab are different for treating osteoporosis than for prevention of skeletal-related events in metastatic breast cancer.","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}